Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Ankylosing Spondylitis Clinical Trial Analysis Report Overview
A total of 1,072 Ankylosing Spondylitis clinical trials were conducted as of January 2024. The Ankylosing Spondylitis clinical trial report provides a comprehensive understanding of the Ankylosing Spondylitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · China
· Russia · Germany · South Korea · United States |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Pfizer Inc
· Novartis AG · AbbVie Inc · Johnson & Johnson · C. H. Boehringer Sohn AG & Co KG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Ankylosing Spondylitis Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Ankylosing Spondylitis clinical trials landscape with more than 30% of the clinical trials conducted as of January 2024.
The key regions considered for Ankylosing Spondylitis clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, China had the highest number of Ankylosing Spondylitis clinical trials, as of January 2024. Belgium had the highest average patient enrollment of Ankylosing Spondylitis clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Germany had the highest proportion of Ankylosing Spondylitis to Musculoskeletal Disorders clinical trials as of January 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia had the highest proportion of Ankylosing Spondylitis to Musculoskeletal Disorders clinical trials as of January 2024.
Ankylosing Spondylitis Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Ankylosing Spondylitis Clinical Trials
Download a Free Sample Report
Ankylosing Spondylitis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Ankylosing Spondylitis clinical trials are company, institution, and the government. As of January 2024, more than 60% of Ankylosing Spondylitis clinical trials conducted were sponsored by company sponsor type, followed by the institution.
Ankylosing Spondylitis Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Ankylosing Spondylitis Clinical Trials Sponsor Types
Ankylosing Spondylitis Clinical Trials - Competitive Landscape
In 2023, Pfizer Inc conducted the highest number of Ankylosing Spondylitis clinical trials
A few of the leading sponsors for Ankylosing Spondylitis clinical trials are:
- Pfizer Inc
- Novartis AG
- AbbVie Inc
- Johnson & Johnson
- H. Boehringer Sohn AG & Co KG
Ankylosing Spondylitis Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy the Full Report to Know More About the Leading Players of Ankylosing Spondylitis Clinical Trials
Segments Covered in the Report
Ankylosing Spondylitis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Ankylosing Spondylitis Clinical Trials Country Outlook (2023)
- China
- Russia
- Germany
- South Korea
- United States
Ankylosing Spondylitis Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulating key investment strategies.
- Identify time-saving and cost-efficient locations to conduct clinical trials.
- Get top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand the clinical trial assessment of the indication on a global, regional, and country level.
Novartis AG
AbbVie Inc
Johnson & Johnson
C. H. Boehringer Sohn AG & Co KG
UCB SA
Merck & Co Inc
Sandoz Group AG
Celltrion Inc
Pamplona Capital Management LLP
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Ankylosing Spondylitis clinical trials in January 2024?
Asia-Pacific accounted for the highest number of Ankylosing Spondylitis clinical trials as of January 2024.
-
Asia-Pacific accounted for the highest number of Ankylosing Spondylitis clinical trials as of January 2024.
China conducted the highest number of Ankylosing Spondylitis clinical trials as of January 2024.
-
Which sponsor type was the most prominent in the Ankylosing Spondylitis clinical trials in January 2024?
As of January 2024, most of the Ankylosing Spondylitis clinical trials conducted were sponsored by company sponsor type.
-
Which are the leading sponsors of Ankylosing Spondylitis clinical trials?
A few of the leading sponsors of Ankylosing Spondylitis clinical trials are Pfizer Inc, Novartis AG, AbbVie Inc, Johnson & Johnson, and C. H. Boehringer Sohn AG & Co KG, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.